Related Experiment Videos
Hepatitis C 2002 guidelines: summary and annotations
H Orlent1, J M Vrolijk, B J Veldt
1Dept. of Hepatology and Gastroenterology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Scandinavian Journal of Gastroenterology. Supplement
|January 28, 2004
Summary
All patients with chronic hepatitis C should be considered for antiviral therapy. Experienced physicians can effectively manage treatment side effects and improve patient adherence for better outcomes.
Area of Science:
- Hepatology
- Infectious Diseases
- Gastroenterology
Background:
- Current National Institutes of Health (NIH) and French guidelines offer clear protocols for hepatitis C patient care.
- Diagnosis and initial investigations for hepatitis C are now well-defined.
Purpose of the Study:
- To review and discuss current guidelines and treatment strategies for chronic hepatitis C.
- To highlight the expanded criteria for antiviral therapy and management of patient adherence.
Main Methods:
- Literature review and expert discussion.
- Analysis of current consensus guidelines and clinical trial data.
Main Results:
- Antiviral therapy is now recommended for a broader range of patients, including those with moderate fibrosis and previously excluded groups like alcohol users and inmates.
- Improved sustained viral response rates observed with newer therapies, attributed to better management of side effects and enhanced patient adherence.
- Dose reduction, rather than treatment cessation, is crucial for managing side effects. Adjunctive therapies like antidepressants can address mood disorders.
Conclusions:
- Every patient diagnosed with chronic hepatitis C warrants consideration for antiviral treatment.
- Treatment by physicians experienced in managing side effects and supporting patients through therapy is recommended for optimal results.